Acquired inhibitor of the intrinsic pathway in a non-haemophilic patient.: Control of bleeding by recombinant factor VIIa

被引:2
作者
Lecumberri, R [1 ]
Panizo, C [1 ]
Páramo, JA [1 ]
Salazar, MP [1 ]
Rocha, E [1 ]
机构
[1] Univ Navarra, Univ Navarra Clin, Serv Hematol & Hemoterapia, E-31080 Pamplona, Spain
关键词
acquired inhibitor; intrinsic pathway; factor IX; recombinant factor VIIa; prednisone;
D O I
10.1046/j.1365-2141.2002.380712.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:284 / 285
页数:2
相关论文
共 5 条
[1]  
Feinstein Donald I., 1995, P1742
[2]  
Hay CRM, 1997, THROMB HAEMOSTASIS, V78, P1463
[3]   PROLONGED ACTIVATED PARTIAL THROMBOPLASTIN TIME OF UNKNOWN ETIOLOGY - A PROSPECTIVE-STUDY OF 100 CONSECUTIVE CASES REFERRED FOR CONSULTATION [J].
KITCHENS, CS .
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 27 (01) :38-45
[4]  
Lusher JM, 1996, HAEMOSTASIS, V26, P124
[5]   The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa [J].
Negrier, C ;
Hay, CRM .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04) :407-412